MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
CRIS — Curis Inc
NasdaqCuris Inc
$0.80
-0.03(-3.29%)
- O
- 0.84
- H
- 0.84
- L
- 0.80
- V
- 99.48K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About CRIS
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
SectorNot available
IPO DateAug 1, 2000
Employees24
Stock ExchangeNasdaq
Ticker SymbolCRIS
Websitehttps://www.curis.com
Key Financial Statistics
| Market Cap | $2.01M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.18 - $6.74 |
| 52-Week Avg Volume | 1.02M |
| VWAP | $0.82 |
| Transactions | 466 |
| Total Recorded Bars | 6,581 days |